Marietta Investment Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-82,999
Closed -$4.22M 167
2025
Q4
$4.22M Sell
82,999
-16,311
-16% -$834K 0.84% 36
2025
Q3
$5.51M Sell
99,310
-22,649
-19% -$1.33M 1.06% 28
2025
Q2
$8.42M Sell
121,959
-9,285
-7% -$632K 1.84% 14
2025
Q1
$9.11M Sell
131,244
-14,454
-10% -$1.19M 2.2% 11
2024
Q4
$12.5M Sell
145,698
-19,595
-12% -$2.12M 2.76% 6
2024
Q3
$19.7M Sell
165,293
-1,144
-0.7% -$153K 4.18% 3
2024
Q2
$23.8M Sell
166,437
-2,800
-2% -$371K 5.22% 3
2024
Q1
$21.7M Buy
169,237
+213
+0.1% +$25.4K 4.75% 3
2023
Q4
$17.5M Buy
169,024
+14,982
+10% +$1.48M 4.35% 3
2023
Q3
$14M Buy
154,042
+1,818
+1% +$160K 3.93% 3
2023
Q2
$12.3M Buy
152,224
+29,122
+24% +$2.38M 3.19% 4
2023
Q1
$9.8M Sell
123,102
-3,070
-2% -$218K 2.73% 6
2022
Q4
$8.54M Sell
126,172
-18
-0% -$1.05K 2.42% 8
2022
Q3
$7.09M Sell
126,190
-1,496
-1% -$80.1K 2.11% 13
2022
Q2
$7.11M Buy
127,686
+1,372
+1% +$76.1K 2.12% 10
2022
Q1
$7.01M Sell
126,314
-2,160
-2% -$111K 1.6% 17
2021
Q4
$7.2M Buy
128,474
+1,940
+2% +$105K 1.52% 17
2021
Q3
$6.07M Buy
126,534
+540
+0.4% +$26.1K 1.39% 21
2021
Q2
$5.28M Sell
125,994
-6,200
-5% -$240K 1.2% 27
2021
Q1
$4.46M Sell
132,194
-708
-0.5% -$25.2K 1.1% 30
2020
Q4
$4.64M Buy
132,902
+816
+0.6% +$28.2K 1.18% 30
2020
Q3
$4.58M Buy
132,086
+17,352
+15% +$578K 1.39% 24
2020
Q2
$3.76M Buy
114,734
+16,884
+17% +$539K 1.25% 25
2020
Q1
$2.94M Buy
97,850
+14,190
+17% +$423K 1.26% 24
2019
Q4
$2.42M Buy
83,660
+1,400
+2% +$38.8K 0.79% 36
2019
Q3
$2.13M Hold
82,260
0.73% 32
2019
Q2
$2.1M Sell
82,260
-10,200
-11% -$252K 0.69% 38
2019
Q1
$2.42M Hold
92,460
0.76% 44
2018
Q4
$2.13M Sell
92,460
-22,200
-19% -$493K 0.81% 42
2018
Q3
$2.7M Hold
114,660
0.8% 41
2018
Q2
$2.64M Hold
114,660
0.82% 36
2018
Q1
$2.82M Hold
114,660
0.85% 36
2017
Q4
$3.08M Hold
114,660
0.87% 36
2017
Q3
$2.76M Hold
114,660
0.83% 40
2017
Q2
$2.46M Sell
114,660
-2,000
-2% -$40.4K 0.79% 41
2017
Q1
$2M Sell
116,660
-96,014
-45% -$1.67M 0.67% 45
2016
Q4
$3.81M Sell
212,674
-56,918
-21% -$1.03M 1.34% 30
2016
Q3
$5.61M Sell
269,592
-108,174
-29% -$2.68M 1.82% 18
2016
Q2
$10.2M Sell
377,766
-2,800
-0.7% -$76.8K 3.63% 3
2016
Q1
$10.3M Sell
380,566
-5,144
-1% -$138K 4.25% 2
2015
Q4
$11.2M Sell
385,710
-328
-0.1% -$9.08K 4.52% 2
2015
Q3
$10.7M Buy
386,038
+4,490
+1% +$127K 4.16% 2
2015
Q2
$10.4M Sell
381,548
-8,836
-2% -$248K 4.06% 2
2015
Q1
$10.4M Sell
390,384
-8,550
-2% -$197K 4.08% 1
2014
Q4
$8.44M Buy
398,934
+20,758
+5% +$464K 3.39% 3
2014
Q3
$9M Buy
378,176
+1,934
+0.5% +$44.5K 4% 1
2014
Q2
$8.69M Sell
376,242
-33,606
-8% -$742K 3.6% 1
2014
Q1
$9.36M Sell
409,848
-10,872
-3% -$232K 3.62% 1
2013
Q4
$7.77M Sell
420,720
-58,700
-12% -$1.02M 2.83% 5
2013
Q3
$8.11M Sell
479,420
-18,620
-4% -$313K 3.22% 2
2013
Q2
$7.72M Buy
+498,040
New +$8.29M 3.34% 2

Other funds holding NVO

Marietta Investment Partners's NVO Position: Q1 2026 in Review

Marietta Investment Partners sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 82,999 shares — an estimated $4.22M sold.

Marietta Investment Partners first reported a position in NVO in Q2 2013 and held it in 51 quarters. The position peaked at $23.8M in Q2 2024. 1,276 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Marietta Investment Partners reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Marietta Investment Partners sold 82,999 Novo Nordisk shares in Q1 2026, an estimated $4.22M.
  • Marietta Investment Partners first reported a position in Novo Nordisk in Q2 2013 and held it in 51 quarters.
  • Marietta Investment Partners's Novo Nordisk position peaked at $23.8M in Q2 2024.
  • 1,276 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Marietta Investment Partners's 13F filing for Q1 2026, filed 28 Apr 2026.